Methyl Phosphonate

Methyl Phosphonate

SCHEMBL4381295

CP(=O)(O)O.c1ccc(CNc2c3ccccc3cc3ccccc23)cc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
POLB P06746 1/20 0.53
RAD52 P43351 1/20 0.53
CDC25B P30305 1/20 0.48
ACP3 P15309 1/20 0.45
CD38 P28907 1/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
KDM4E B2RXH2 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.41
APP P05067 1/20 0.40
ACHE P22303 1/20 0.40
GAA P10253 1/20 0.40
IDO1 P14902 1/20 0.40
HDAC1 Q13547 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
GSK3B P49841 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851619 0.87 KMT2A (0.67) KMT2APOLBRAD52CDC25BALDH1A1
SCHEMBL27804272 0.81 KMT2A (0.49) KMT2APOLBRAD52CDC25BCD38
Methyl Phosphonate SCHEMBL4387220 0.78 TOP2A (0.42) POLBRAD52HDAC1
Methyl Phosphonate SCHEMBL4397039 0.75 KCNH3 (0.41) KMT2APOLBRAD52ALDH1A1KDM4E
SCHEMBL11640078 0.71 TSHR (0.60) KMT2AALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL18415472 0.71 KMT2A (0.54) KMT2AALDH1A1HPGDKDM4ESMN1; SMN2
Anthracene SCHEMBL28304429 0.70 PTPN1 (0.47) KMT2AACP3ALDH1A1HPGDKDM4E
SCHEMBL1868598 0.70 RAD52 (1.00) KMT2APOLBRAD52ALDH1A1HPGD
Methyl Phosphonate SCHEMBL5686064 0.70 HDAC6 (0.40) KMT2AACP3ALDH1A1HPGDKDM4E
SCHEMBL6858682 0.69 ALDH1A1 (0.44) KMT2APOLBRAD52ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101730565-B Substituted phosphonates and their use for reducing amyloid aggregates QUEEN MARY & WESTFIELD COLLEGE 2015-06-10 CN disclosed
US-7629379-B2 Substituted phosphonate fluorescent sensors and use thereof QUEEN MARY & WESTFIELD COLLEGE (GB) 2009-12-08 US disclosed
US-20070049761-A1 Substituted phosphonate fluorescent sensors and use thereof QUEEN MARY & WESTFIELD COLLEGE (GB) 2007-03-01 US disclosed
EP-1625134-A2 SUBSTITUTED PHOSPHONATE FLUORESCENT SENSORS AND USE THEREOF QUEEN MARY & WESTFIELD COLLEGE (GB) 2006-02-15 EP disclosed
WO-2004101579-A2 SUBSTITUTED PHOSPHONATE FLUORESCENT SENSORS AND USE THEREOF QUEEN MARY & WESTFIELD COLLEGE (GB) 2004-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049761-A1 Substituted phosphonate fluorescent sensors and use thereof NR2E3, CASR, NR3C2 KMT2A 3756/4885POLB 2167/4885RAD52 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.